Cas:41039-54-7 N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride manufacturer & supplier

Chemical Name:N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride

CAS.NO:41039-54-7

Synonyms:N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride

Molecular Formula:C₁₂H₁₃Cl₃N₂

Molecular Weight:291.60400

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:24.92000

Exact Mass:290.01400

LogP:5.02410

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride Use and application,N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride technical grade,usp/ep/jp grade.

Related News: The patient, who arrived from Wuhan, is ��stable and under medical care,�� the ministry said in a statement, adding there is ��no cause for concern�� for the public. N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride manufacturer The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI). N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride supplier There’s a few factors that play into this. N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride vendor Green Valley said it would launch the drug ��very soon�� in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug. N-[(2-chlorophenyl)methyl]pyridin-4-amine,dihydrochloride factory The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).